Food supplements as part of the OTC Market

Transcription

1 1/16/218 Food supplements as part of the OTC Market Hynek Valerián, IQVIA Copyright 218 IQVIA. All rights reserved. + Global and European context for OTC market Table of Contents + Czech Republic OTC and food supplements market Trends and key categories Elements of growth Sales channels: Pharmacy chains & internet Key players 1 1

2 1/16/218 While OTC growth remains in the 4-5% range, there are continued signs of a market slowdown; Pharma growth slows significantly. Source: IMS OTC audits plus estimates (Excluding Venezuela) 2 The developed Western Europe benchmark shows the potential for increase in OTC expenditure elsewhere in the region; Africa experiences the strongest growth rates. Source: IMS OTC Global Analysis 3 2

3 1/16/218 Higher spend in Western Europe is a reflection of its higher prices. ME see the greatest increases in average OTC prices. Source: IMS OTC Global Analysis 4 Most CEE countries experience growth above the European average and stable or increasing, Russia being the most significant exception. Source: IMS OTC Global Analysis Sanctions disrupt the economy with long-term decline in disposable income reaching the OTC market. 5 3

4 1/16/218 Consumer spend on OTCs is increasing across most European countries, in WE growth is generally 2-4%, while in CEE growth is generally 6-9%. Source: IMS OTC Global Analysis 6 Free IQVIA report: Get Ahead of Consumer Health Trends Across the Globe Learn about how the global consumer healthcare environment looks now how the consumer is evolving and how you can play and win across the 3Ds of the digital sphere: Digital Health, Digital Engagement and Digital Trade. For more info on Global trends follow us 7 4

5 1/16/218 Czech Republic 8 Terminology note: Food Supplements as part of OTC Market Rx bound Non Rx-bound (Total OTC) Semi ethical Self- Medication Sold with Rx Sold without Rx registered registered non-registered Food Supplements OTC_ 9 5

6 CZK (bln, ex-mnf price) Packs (mil) CZK (bln, ex-mnf price) Packs (mil) 1/16/218 Czech pharmaceutical market Retail pharmacies, MAT/8/218 Volume Values (mnf price) 17% 11% 251 mil packs 54% 16% 39.2 bln CZK 29% 73% Rx bound Non Rx bound Non registered OTC Rx bound Non Rx bound Non registered OTC 1 Sales of medicines and OTC Czech Republic Retail pharmacies MAT/8/216 +3,6% +4,9% MAT/8/217 MAT/8/ MAT/8/216 -,2% +,9% MAT/8/217 MAT/8/ ,8% +5,7% MAT/8/216 MAT/8/217 MAT/8/218 +,3% +3,7% MAT/8/216 MAT/8/217 MAT/8/218 Non-registered OTC OTC medicines Rx bound medicines 11 6

7 CZK (bln, ex-mnf price) Packs (mil) CZK (bln, ex-mnf price) Packs (mil) 1/16/218 OTC medicines and non-registered OTCs trends Retail pharmacies ,9% +5,9% MAT/8/216 MAT/8/217 MAT/8/ ,4% +2,5% MAT/8/216 MAT/8/217 MAT/8/ ,6% +5,2% ,4% +5,7% MAT/8/216 MAT/8/217 MAT/8/218 MAT/8/216 MAT/8/217 MAT/8/218 Non-registered OTC OTC medicines 12 Leading OTC categories: share of non-registered products differs Czech Republic retail pharmacies, MAT 8/218 Bln CZK, ex-mnf price,,5 1, 1,5 2, 2,5 3, Annual growth (%) Growth contribution (mil CZK) cough&cold 16% 6,8 pain relief 24% 5,6 digestives 4% 5,3 vitamins skin treatment 8% 29% 3,8 3,9 urinary&reprod. 69% 2, circulatory 33% 4,4 others 71% 9,7 5,7 % OTC Medicines Non-registered OTC 13 7

8 % CZK MAT 8/217 Non- reg. OTC % CZK MAT 8/217 % CZK MAT 8/217 Registered OTC Mil CZK, ex-mnf price 1/16/218 Key OTC categories are main contributors to OTC market growth Czech Republic retail pharmacies, MAT 8/218 Share of OTC categories 12% 5% 24% 6% 8% 19% 13% 13% cough&cold digestives skin treatment pain relief vitamins urinary&reprod. circulatory others Growth contribution % 19% 12% 9% 6% 2% 2% 4% The leading 4 OTC1 categories representing 7% of the market delivered 7% of the total OTC market growth. Strong growth observed for some categories in the others group. In the group of others, main contributors are eye care, tonics&stimulants, weight loss and calm sleep products 14 Innovations are the main contributor to the growth of the food supplements segment 11 +5,7% 11 +6,% , 2,7 1,4 1,1 1,7 1, 15, , 3,4 1,2,3,5,5 16, MAT 8/217 Price Volume Mix New packs New MAT products 8/218 MAT 8/17 Price Volume Mix New packs New products MAT 8/18 The key drivers of the OTC market growth are the new launches/innovations together with price increase Whilst the price growth of registered OTCs is a key growth contributor, non-registered OTC segment sees more from innovations that more than offset the negative impact of change of the product mix , MAT 8/17 1,7 Price 1,7 Volume +5,2% 3,2 Mix 3,4 New packs 1,6 New products 15,2 MAT 8/

9 1/16/218 Growth factors summary Wholesaler sell in data, retail pharmacies, MAT 8/218 Price Volume ("old" products) Product Mix New packs New products Growth Registered Rx bound Registered OTC Non-registered OTC -,6% -,6% 4,% 1,4%,5% 4,7% 3,4% 1,2%,3%,5%,5% 6,% 1,7% 1,7% -3,2% 3,4% 1,6% 5,2% Price Volume ("old" products) Product Mix New packs New products Growth Registered Rx bound Registered OTC Non-registered OTC -2,8% -1,1% 2,2%,9%,5% -,3% 2,% -1,3% 1,8% 1,1%,6% 4,1% 1,5% 3,5% -1,3% 2,6% 3,1% 9,4% 16 Closer look at sales channels: Pharmacy chains and e-commerce 17 9

10 Growth Growth Turnover (mld CZK) 1/16/218 Czech chains dominate in the OTC sales Retail pharmacies, MAT 8/ Dr. Max Non chain Moje lekarna Alphega Benu Pharmapoint Magistra Copharm Agel Others RX BOUND NON-RX BOUND OTC - NON registered 18 Dynamics of the OTC medicines and non-registered OTCs varies between chains, reflecting the general CH focus Retail pharmacies, MAT 8/218 OTC medicines Non-registered OTC 2% Magistra Alphega 2% Magistra Benu 15% 15% Benu 1% Dr. Max Pharmapoint 5% Ipc % Copharm Moje lekarna Non chain -5% Others -1% % 1% 2% 3% 4% Market Share Alphega 1% Others Pharmapoint Dr. Max 5% % Copharm Non chain -5% Moje lekarna -1% % 1% 2% 3% 4% Market Share 19 1

11 Number of products Turnover (mld CZK) Number of products Turnover (mil CZK) # Products - registered OTC # Products non registered OTC # Products - registered OTC # Products non registered OTC 1/16/218 Whilst pharmacies typically handle >1/2 of OTC medicines brands, its less than 1/3 for FS Handled brands Handled brands OTC Reg OTC Non Reg OTC Reg OTC Non Reg Reg 9% Reg 5% Non Reg 9% Non Reg 5% Reg 9% Reg 5% Non Reg 9% Non Reg 5% 2 Unlike for registered OTCs, full pharmacy coverage is reserved only for minor part of FS portfolio 18 Non Rx bound medicines 6 2 Non registered OTC % of handling pharmacies % of handling pharmacies 21 11

12 1/16/218 Internet pharmacies gaining importance for OTC portfolio 1% 98% 96% 2,2% Total OTC 3,3% 4,7% 1% 98% 96% Registered OTC 1,1% 1,7% 2,3% 1% 98% 96% Non-registered OTC 3,6% 5,5% 7,7% 94% 92% 9% 97,8% 96,7% 95,3% % 92% 9% 98,9% 98,3% 97,7% % 92% 9% 96,4% ,5% ,3% 218 INTERNET PHARMACY STREET PHARMACY INTERNET PHARMACY STREET PHARMACY INTERNET PHARMACY STREET PHARMACY 22 Key players 23 12

13 /16/218 TOP 3 corporations in Czech OTC market (by turnover in ex-mnf prices, retail pharmacies) CORPORATION RNK MAT 8/ CORPORATION RNK MAT 8/ SANOFI PERRIGO GLAXOSMITHKLINE MERCK KGAA TEVA RECORDATI WALMARK PFIZER DR. MAX GLENMARK JOHNSON & JOHNSON VALEANT PHARMA SIMPLY YOU BGP PRODUCTS NOVARTIS KRKA BAYER APOTEX RB BOIRON MENARINI THEISS NATURWAREN ANGELINI NESTLE GREEN SWAN TEREZIA COMPANY STADA ATRIUM INNOVATION SCHWABE CEMIO What is the perception of OTC companies by their customers? Find out in IQVIA OTC Mirror (coming in November 218) 24 Please Contact Us for More Information Hynek Valerián Associate Director Offering Management, CZ&SK hynek.valerian@iqvia.com

14 1/16/